Lichen Xu

637 total citations
30 papers, 480 citations indexed

About

Lichen Xu is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Lichen Xu has authored 30 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in Lichen Xu's work include Liver Disease and Transplantation (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Renal Diseases and Glomerulopathies (3 papers). Lichen Xu is often cited by papers focused on Liver Disease and Transplantation (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Renal Diseases and Glomerulopathies (3 papers). Lichen Xu collaborates with scholars based in China and Taiwan. Lichen Xu's co-authors include Lanjuan Li, Meifang Yang, Hainv Gao, Jianhua Hu, Weihang Ma, Zhi Chen, Huihui Dong, Longxian Lv, Qiaomai Xu and Gang Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Lichen Xu

28 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lichen Xu China 12 163 133 120 65 60 30 480
Amre Nasr Saudi Arabia 18 172 1.1× 172 1.3× 43 0.4× 41 0.6× 46 0.8× 50 705
Douglas L. Hurley United States 13 174 1.1× 31 0.2× 198 1.6× 115 1.8× 41 0.7× 22 527
Maria Delgado Spain 7 76 0.5× 225 1.7× 80 0.7× 100 1.5× 29 0.5× 15 574
Longxian Lv China 15 106 0.7× 305 2.3× 232 1.9× 25 0.4× 32 0.5× 27 599
Marie Françoise Tripodi Italy 9 340 2.1× 78 0.6× 110 0.9× 84 1.3× 43 0.7× 23 504
Xinjing Wang China 14 197 1.2× 85 0.6× 150 1.3× 47 0.7× 30 0.5× 28 519
Williams Walana Ghana 16 103 0.6× 168 1.3× 60 0.5× 38 0.6× 36 0.6× 46 597
Jiyuan Zhou China 14 158 1.0× 119 0.9× 49 0.4× 27 0.4× 52 0.9× 24 486
Maria Imaculada Muniz‐Junqueira Brazil 19 158 1.0× 163 1.2× 68 0.6× 65 1.0× 58 1.0× 59 889
Craig B. Webb United States 18 120 0.7× 310 2.3× 165 1.4× 221 3.4× 121 2.0× 49 999

Countries citing papers authored by Lichen Xu

Since Specialization
Citations

This map shows the geographic impact of Lichen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lichen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lichen Xu more than expected).

Fields of papers citing papers by Lichen Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lichen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lichen Xu. The network helps show where Lichen Xu may publish in the future.

Co-authorship network of co-authors of Lichen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lichen Xu. A scholar is included among the top collaborators of Lichen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lichen Xu. Lichen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Lichen, Changwei W. Wu, & Guisen Li. (2025). Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review. Journal of Nephrology. 38(6). 1557–1564.
2.
Xu, Lichen, Xiaoping Zheng, Hainv Gao, et al.. (2024). Elevated CD169 expressing monocyte/macrophage promotes systemic inflammation and disease progression in cirrhosis. Clinical and Experimental Medicine. 24(1). 45–45. 5 indexed citations
3.
Zheng, Xiaoping, Gang Wang, Mengfei Zhu, et al.. (2023). Plasma human neutrophil peptides as biomarkers of disease severity and mortality in patients with decompensated cirrhosis. Liver International. 43(5). 1096–1106. 2 indexed citations
4.
Yang, Dongfang, et al.. (2022). Diagnosis and Treatment of Cervical Spondylotic Radiculopathy Using Selective Nerve Root Block (SNRB): Where are We Now?. Pain and Therapy. 11(2). 341–357. 9 indexed citations
5.
6.
Xu, Lichen, et al.. (2022). Effects of different blood pressures and their long-term variability on the development of diabetic kidney disease in patients with type 2 diabetes mellitus. Clinical and Experimental Hypertension. 44(5). 464–469. 1 indexed citations
7.
Wu, Fengtian, Hainv Gao, Xiaoping Zheng, et al.. (2021). Reduced Energy Metabolism Impairs T Cell-Dependent B Cell Responses in Patients With Advanced HBV-Related Cirrhosis. Frontiers in Immunology. 12. 660312–660312. 10 indexed citations
8.
Wang, Haoyu, et al.. (2021). MicroRNA-140-5p is Downregulated in Osteosarcoma and Overexpression of MicroRNA-140-5p Inhibits Cancer Cell Proliferation by Downregulating GLUT-1. OncoTargets and Therapy. Volume 14. 995–1002. 4 indexed citations
9.
Wang, Gang, Jun Guan, Guojun Li, et al.. (2021). Potential capacity of interferon-α to eliminate covalently closed circular DNA (cccDNA) in hepatocytes infected with hepatitis B virus. Gut Pathogens. 13(1). 22–22. 15 indexed citations
10.
Wang, Yunyun, Fengtian Wu, Chao Chen, et al.. (2021). Soluble urokinase plasminogen activator receptor is associated with short-term mortality and enhanced reactive oxygen species production in acute-on-chronic liver failure. BMC Gastroenterology. 21(1). 429–429. 4 indexed citations
11.
Wang, Gang, et al.. (2021). Role of bile acids in liver diseases mediated by the gut microbiome. World Journal of Gastroenterology. 27(22). 3010–3021. 40 indexed citations
12.
Liu, Yi, et al.. (2019). Resveratrol alleviates lipopolysaccharide-induced inflammation in PC-12 cells and in rat model. BMC Biotechnology. 19(1). 10–10. 37 indexed citations
13.
Xu, Lichen, Jianhua Hu, Yunyun Wang, et al.. (2018). Pneumonia in patients with cirrhosis: risk factors associated with mortality and predictive value of prognostic models. Respiratory Research. 19(1). 242–242. 27 indexed citations
14.
Shi, Ding, Longxian Lv, Daiqiong Fang, et al.. (2017). Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats. Scientific Reports. 7(1). 6927–6927. 76 indexed citations
15.
Xu, Lichen, Qiaomai Xu, Meifang Yang, et al.. (2016). Nocardiosis in ectopic ACTH syndrome: A case report and review of 11 cases from the literature. Experimental and Therapeutic Medicine. 12(6). 3626–3632. 10 indexed citations
16.
Fan, Jun, Meifang Yang, Lichen Xu, et al.. (2016). Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation. International Journal of Infectious Diseases. 46. 89–93. 17 indexed citations
17.
Zhao, Hong, Lichen Xu, Huihui Dong, et al.. (2015). Correlations between Clinical Features and Mortality in Patients with Vibrio vulnificus Infection. PLoS ONE. 10(8). e0136019–e0136019. 27 indexed citations
18.
Zhang, Yimin, Wei Yu, Ning Zhou, et al.. (2015). High frequency of thrombocytopenia in patients with acute-on-chronic liver failure treated with linezolid. Hepatobiliary & pancreatic diseases international. 14(3). 287–292. 19 indexed citations
19.
Xu, Lichen, et al.. (2015). Well-differentiated angiosarcoma of spleen: a teaching case mimicking hemagioma and cytogenetic analysis with array comparative genomic hybridization. World Journal of Surgical Oncology. 13(1). 300–300. 6 indexed citations
20.
Yang, Meifang, Min Xu, Wei Wei, et al.. (2014). Clinical findings of 40 patients with nocardiosis: A retrospective analysis in a tertiary hospital. Experimental and Therapeutic Medicine. 8(1). 25–30. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026